title: Differential expression of collagen type IV alpha-chains in the tubulointerstitial compartment in experimental chronic serum sickness nephritis.
abstract: The expression of collagen type IV chains in the renal tubulointerstitium was investigated during the development of chronic serum sickness (CSS) in rats, a model for immune complex-mediated renal disease. Immunohistochemical studies showed increased expression of alpha4(IV) collagen early during disease development, followed by an increase in alpha1(IV) through alpha3(IV) collagen subchain expression, especially in the tubular basement membrane. Dot-blot and in situ hybridization analysis showed a transient increase in steady-state mRNA levels for all collagen IV subchains during the development of CSS, which was most abundant for alpha1(IV), alpha2(IV), and alpha4(IV). Statistical correlations were found between the mRNA levels of alpha1(IV) and alpha2(IV) collagen and between alpha3(IV) and alpha4(IV), in line with the results of others which showed that these chains are co-distributed as heterotrimer collagen type IV molecules. However, additional correlations were found between the mRNA levels coding for alpha1(IV) and alpha3(IV) collagen, and between alpha1(IV) and alpha4(IV) mRNAs in the course of CSS. These abnormal correlations support the hypothesis that changes occur in the co-expression of the collagen IV subchains during the development of CSS. In addition, a strong correlation was found between the presence in the tubulointerstitium of alpha1(IV) and alpha2(IV) collagen chains, on the one hand, and the tubulointerstitial influx of R73+ and ED1+ cells, on the other, suggesting the involvement of inflammatory cells in the observed alterations in matrix production. Changes in the relative abundance of collagen IV chains in disease states may perturb the collagen IV network in the tubulointerstitial compartment and thereby play a role in the development of renal failure.
authors.affiliation: Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: A I
authors.initials: AI
authors.lastname: Van Vliet
authors.forename: I E
authors.initials: IE
authors.lastname: Van Alderwegen
authors.forename: H J
authors.initials: HJ
authors.lastname: Baelde
authors.forename: E
authors.initials: E
authors.lastname: de Heer
authors.forename: P D
authors.initials: PD
authors.lastname: Killen
authors.forename: R K
authors.initials: RK
authors.lastname: Kalluri
authors.forename: J A
authors.initials: JA
authors.lastname: Bruijn
authors.forename: E C
authors.initials: EC
authors.lastname: Bergijk
mesh_terms: D000818:Animals; D002908:Chronic Disease; D003094:Collagen / Q000235:genetics / Q000378:metabolism*; D005260:Female; D015870:Gene Expression; D005921:Glomerulonephritis / Q000378:metabolism*; D007124:Immunoenzyme Techniques; D017403:In Situ Hybridization; D007684:Kidney Tubules / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017208:Rats, Wistar; D012713:Serum Sickness / Q000378:metabolism*
chemical_list: D012333:RNA, Messenger; D003094:Collagen